SEM cathodoluminescent imaging using up-converting nanophosphors

• US 20060269483A1
• Filed: 07/27/2006
• Published: 11/30/2006
• Est. Priority Date: 02/28/2005
• Status: Abandoned Application

• Current Assignee: The Trustees of Princeton University (Princeton University)
• Original Assignee: The Trustees of Princeton University (Princeton University)
• Inventors: Riehm, Robert, Lim, Shuang Fang, Austin, Robert
• Application Number:
  US11/494,157
• Publication Number:
  US 20060269483A1
• Time in Patent Office: Days
• US Class Current: 424/9.600
• CPC Class Codes: A61K 49/0067 quantum dots, fluorescent nanocrystals
• CPC Class Codes: H01J 2237/2808 Cathodoluminescence

Abstract

Methods for high resolution tissue imaging in which a tissue to be imaged is labeled with UCP'"'"'s coupled to probes that bind specifically to biological markers on the tissue; the UCP'"'"'s are then excited with electrons so that the UCP'"'"'s emit cathodoluminescent photons; after which the photon emission is converted to a visible image. Methods for measuring water content, blood content or blood oxygenation in tumor tissue are also disclosed.

Claims

1. A method for high resolution tissue imaging comprising labeling a tissue to be imaged with UCP'"'"'s coupled to probes that bind specifically to biological markers on said tissue;

exciting said UCP'"'"'s with electrons so that said UCP'"'"'s emit cathodoluminescent photons; and

converting the photon emission to a visible image.

2. The method of claim 1, wherein said UCP'"'"'s have a particle size less than about 50 nm.

3. The method of claim 2, wherein said UCP'"'"'s have a particle size between about 5 and about 30 nm.

4. The method of claim 1, wherein said probe is selected from the group consisting of antibodies, streptavidin, protein A, polypeptide ligands of cellular receptors, polynucleotide probes, drugs, antigens and toxins.

5. The method of claim 1, wherein said UCP'"'"'s comprise a phosphor host material selected from the group consisting of sodium yttrium fluoride, lanthanum fluoride, lanthanum oxysulfide, yttrium oxysulfide, yttrium fluoride, yttrium gallate, yttrium aluminum garnet, gadolinium fluoride, barium yttrium fluoride, and gadolinium oxysulfide.

6. The method of claim 1, wherein said UCP'"'"'s comprise an activator couple selected from the group consisting of ytterbium/erbium, ytterbium/thulium and ytterbium/holmium.

7. The method of claim 1, wherein said UCP'"'"'s comprise an activator couple, wherein the absorber is ytterbium and the emitting center is selected from the group consisting of erbium, holmium, terbium and thulium.

8. The method of claim 7, wherein said emitting center is erbium.

9. The method of claim 1, wherein said electrons have an energy between about 20 and about 30 keV.

10. The method of claim 1, wherein said electrons are produced by a Scanning Electron Microscope.

11. The method of claim 1, wherein the wavelength of said photons is in the visible spectrum.

12. The method of claim 1, wherein the photon emission is converted to a visible image using a photomultiplier tube.

13. A method for measuring two or more of water content, blood content or blood oxygenation in tumor tissue comprising, labeling tumor tissue with UCP'"'"'s coupled to probes that bind specifically to biological markers on said tumor;

exciting said UCP'"'"'s with infrared photons or electrons so that said UCP'"'"'s emit luminescent or cathodoluminescent photons; and

converting the photon emission to information on two or more of water content, blood content or blood oxygenation via spectral analysis.

14. The method of claim 13, wherein said analysis is preformed as the tumor is being imaged using dispersed light emitted from excited UCP'"'"'s.

15. The method of claim 13, wherein said UCP'"'"'s are excited with infrared photons.

16. The method of claim 13, wherein said UCP'"'"'s are excited with electrons.

17. The method of claim 16, wherein said electrons have an energy between about 20 and about 30 keV.

18. The method of claim 13, wherein said electrons are supplied by a Scanning Electron Microscope.

19. The method of claim 13, wherein water content, blood content or blood oxygenation in tumor tissue are all measured by spectral analysis.

20. The method of claim 13, wherein said UCP'"'"'s have a particle size less than about 50 nm.

21. The method of claim 13, wherein said UCP'"'"'s comprise an activator couple, wherein the absorber is ytterbium and the emitting center is selected from the group consisting of erbium, holmium, terbium and thulium.